Table 5.
N = 3863 | cfPWV progression (17–24 years) | |||
---|---|---|---|---|
Participants with <90th percentile cIMT (normal cIMT) | Participants with ≥90th percentile cIMT (atherosclerosis) | |||
Effect estimate (95% CI) | p-value | Effect estimate (95% CI) | p-value | |
Cumulative Systolic blood pressure (mmHg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | 0.004 (0.0004–0.007) | 0.028 | 0.005 (−0.014–0.023) | 0.608 |
High category | 0.007 (0.003–0.011) | 0.001 | 0.013 (−0.003–0.028) | 0.102 |
Cumulative Lean mass (kg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | 0.001 (−0.003–0.005) | 0.698 | 0.001 (−0.014–0.016) | 0.903 |
High category | 0.008 (0.002–0.014) | 0.009 | 0.012 (−0.005–0.029) | 0.152 |
Cumulative Total fat mass (kg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | 0.002 (−0.002–0.006) | 0.229 | 0.002 (−0.009–0.014) | 0.694 |
High category | 0.003 (−0.002–0.009) | 0.228 | −0.003 (−0.020–0.014) | 0.755 |
N = 3863 | cIMT progression (17–24 years) | |||
---|---|---|---|---|
Participants with < 90th percentile cfPWV (Optimal stiffness) | Participants with ≥ 90th percentile cfPWV (arteriosclerosis) | |||
Effect estimate (95% CI) | p-value | Effect estimate (95% CI) | p-value | |
Cumulative Systolic blood pressure (mmHg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | 0.001 (−0.002–0.004) | 0.523 | 0.008 (−0.003–0.020) | 0.155 |
High category | 0.008 (0.005–0.011) | <0.0001 | 0.013 (0.001–0.025) | 0.035 |
Cumulative Lean mass (kg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | 0.005 (0.002–0.008) | <0.0001 | 0.0001 (−0.013–0.013) | 0.987 |
High category | 0.010 (0.005 – 0.013) | <0.0001 | 0.002 (−0.012–0.017) | 0.738 |
Cumulative Total fat mass (kg) (9–24 years) | ||||
Low category | Reference | – | Reference | – |
Moderate category | −0.001 (−0.004–0.003) | 0.697 | 0.009 (−0.003–0.020) | 0.130 |
High category | 0.002 (−0.001–0.006) | 0.214 | 0.001 (−0.012–0.013) | 0.895 |
Model was adjusted for age at baseline, sex, time in years from baseline through follow-up, low-density lipoprotein, C-reactive protein, fasting blood glucose, moderate to vigorous physical activity at 24 years, smoking status, and family history of hypertension/diabetes/high cholesterol/vascular disease, in addition to fat mass, systolic blood pressure, and/or lean mass depending on the predictor
A 2-sided P-value < 0.05 (in bold) is considered statistically significant